Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Adenocarcinoma × X-Rays × Clear all

Sponsor

Conditions

Lymphoma, Non-Hodgkin 5 Wilms Tumor 4 Rhabdoid Tumor 4 Neuroectodermal Tumors, Primitive, Peripheral 4 Neuroblastoma 4 Medulloblastoma 4 Histiocytosis, Langerhans-Cell 4 Hepatoblastoma 4 Glioma 4 Ependymoma 4 Sarcoma 3 Rhabdomyosarcoma 3 Osteosarcoma 3 Lung Neoplasms 3 Central Nervous System Neoplasms 3 Breast Neoplasms 3 Sarcoma, Ewing 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neuroendocrine Tumors 2 Malignant Solid Neoplasm 2 Lymphoma 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Burkitt Lymphoma 2 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Thyroid Neoplasms 1 Thrombosis 1 Prostatic Neoplasms 1

Interventions

Gemcitabine 11 Cisplatin 11 Capecitabine 11 Oxaliplatin 9 Fluorouracil 9 130-nm albumin-bound paclitaxel 8 pembrolizumab 7 Paclitaxel 7 Ramucirumab 6 Leucovorin 6 Carboplatin 6 Bevacizumab 6 Pemetrexed 4 Nivolumab 4 Irinotecan 4 Everolimus 4 Erlotinib Hydrochloride 4 Docetaxel 4 Cyclophosphamide 4 Albumin-Bound Paclitaxel 4 trastuzumab deruxtecan 3 Radiotherapy 3 Afatinib 3 zolbetuximab 2 pralsetinib 2 cabozantinib 2 Trastuzumab 2 Ipilimumab 2 vosaroxin 1 vandetanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡